- Home
- CRBP vs LAKE Comparison
CRBP vs LAKE Comparison
Compare CRBP & LAKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- LAKE
- Stock Information
- Founded
- CRBP 2009
- LAKE 1982
- Country
- CRBP United States
- LAKE United States
- Employees
- CRBP 19
- LAKE N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- LAKE Industrial Specialties
- Sector
- CRBP Health Care
- LAKE Health Care
- Exchange
- CRBP Nasdaq
- LAKE Nasdaq
- Market Cap
- CRBP 158.3M
- LAKE 144.9M
- IPO Year
- CRBP N/A
- LAKE 1986
- Fundamental
- Price
- CRBP $13.00
- LAKE $22.88
- Analyst Decision
- CRBP Strong Buy
- LAKE Strong Buy
- Analyst Count
- CRBP 8
- LAKE 2
- Target Price
- CRBP $62.00
- LAKE $27.50
- AVG Volume (30 Days)
- CRBP 313.3K
- LAKE 50.9K
- Earning Date
- CRBP 11-07-2024
- LAKE 12-05-2024
- Dividend Yield
- CRBP N/A
- LAKE 0.52%
- EPS Growth
- CRBP N/A
- LAKE N/A
- EPS
- CRBP N/A
- LAKE N/A
- Revenue
- CRBP N/A
- LAKE $151,822,000.00
- Revenue This Year
- CRBP N/A
- LAKE $34.57
- Revenue Next Year
- CRBP N/A
- LAKE $13.25
- P/E Ratio
- CRBP N/A
- LAKE N/A
- Revenue Growth
- CRBP N/A
- LAKE 23.99
- 52 Week Low
- CRBP $5.25
- LAKE $15.10
- 52 Week High
- CRBP $61.90
- LAKE $26.10
- Technical
- Relative Strength Index (RSI)
- CRBP 25.10
- LAKE 55.65
- Support Level
- CRBP $12.90
- LAKE $22.62
- Resistance Level
- CRBP $16.21
- LAKE $25.32
- Average True Range (ATR)
- CRBP 0.95
- LAKE 1.32
- MACD
- CRBP -0.16
- LAKE -0.04
- Stochastic Oscillator
- CRBP 1.69
- LAKE 53.26
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About LAKE Lakeland Industries Inc.
Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.